These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 34902224)
21. Integrated Care Models for Long Coronavirus Disease. Barshikar S; Laguerre M; Gordon P; Lopez M Phys Med Rehabil Clin N Am; 2023 Aug; 34(3):689-700. PubMed ID: 37419540 [TBL] [Abstract][Full Text] [Related]
22. Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Hope AA; Evering TH Infect Dis Clin North Am; 2022 Jun; 36(2):379-395. PubMed ID: 35636906 [TBL] [Abstract][Full Text] [Related]
23. How an effective response to post-acute sequelae of SARS-CoV-2 infection (PASC) relies on nursing research. Pinto MD; Downs CA; Lambert N; Burton CW Res Nurs Health; 2021 Oct; 44(5):743-745. PubMed ID: 34365670 [No Abstract] [Full Text] [Related]
24. Research progress of post-acute sequelae after SARS-CoV-2 infection. Jiao T; Huang Y; Sun H; Yang L Cell Death Dis; 2024 Apr; 15(4):257. PubMed ID: 38605011 [TBL] [Abstract][Full Text] [Related]
25. Tissue injury and leukocyte changes in post-acute sequelae of SARS-CoV-2: review of 2833 post-acute patient outcomes per immune dysregulation and microbial translocation in long COVID. Islam MS; Wang Z; Abdel-Mohsen M; Chen X; Montaner LJ J Leukoc Biol; 2023 Mar; 113(3):236-254. PubMed ID: 36807444 [TBL] [Abstract][Full Text] [Related]
27. Editorial: Post-Acute Sequelae of SARS-CoV-2 Infection (PASC). Updated Terminology for the Long-Term Effects of COVID-19. Parums DV Med Sci Monit; 2023 Jul; 29():e941595. PubMed ID: 37392031 [TBL] [Abstract][Full Text] [Related]
28. Pre-existing conditions associated with post-acute sequelae of COVID-19. Jacobs ET; Catalfamo CJ; Colombo PM; Khan SM; Austhof E; Cordova-Marks F; Ernst KC; Farland LV; Pogreba-Brown K J Autoimmun; 2023 Feb; 135():102991. PubMed ID: 36634460 [TBL] [Abstract][Full Text] [Related]
29. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Peluso MJ; Deitchman AN; Torres L; Iyer NS; Munter SE; Nixon CC; Donatelli J; Thanh C; Takahashi S; Hakim J; Turcios K; Janson O; Hoh R; Tai V; Hernandez Y; Fehrman EA; Spinelli MA; Gandhi M; Trinh L; Wrin T; Petropoulos CJ; Aweeka FT; Rodriguez-Barraquer I; Kelly JD; Martin JN; Deeks SG; Greenhouse B; Rutishauser RL; Henrich TJ Cell Rep; 2021 Aug; 36(6):109518. PubMed ID: 34358460 [TBL] [Abstract][Full Text] [Related]
30. Cerebrospinal fluid metabolomic and proteomic characterization of neurologic post-acute sequelae of SARS-CoV-2 infection. Chen S; Liang J; Chen D; Huang Q; Sun K; Zhong Y; Lin B; Kong J; Sun J; Gong C; Wang J; Gao Y; Zhang Q; Sun H Brain Behav Immun; 2024 Jan; 115():209-222. PubMed ID: 37858739 [TBL] [Abstract][Full Text] [Related]
31. Postacute Sequelae of SARS-CoV-2: Musculoskeletal Conditions and Pain. Copley M; Kozminski B; Gentile N; Geyer R; Friedly J Phys Med Rehabil Clin N Am; 2023 Aug; 34(3):585-605. PubMed ID: 37419534 [TBL] [Abstract][Full Text] [Related]
32. Postacute sequelae of COVID-19 at 2 years. Bowe B; Xie Y; Al-Aly Z Nat Med; 2023 Sep; 29(9):2347-2357. PubMed ID: 37605079 [TBL] [Abstract][Full Text] [Related]
33. Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) up to 15 Months Post-Infection. Patterson BK; Francisco EB; Yogendra R; Long E; Pise A; Rodrigues H; Hall E; Herrera M; Parikh P; Guevara-Coto J; Triche TJ; Scott P; Hekmati S; Maglinte D; Chang X; Mora-Rodríguez RA; Mora J Front Immunol; 2021; 12():746021. PubMed ID: 35082777 [TBL] [Abstract][Full Text] [Related]
34. Association between D-dimer levels and post-acute sequelae of SARS-CoV-2 in patients from a tertiary care center. Kalaivani MK; Dinakar S Biomark Med; 2022 Aug; 16(11):833-838. PubMed ID: 35787147 [No Abstract] [Full Text] [Related]
35. Postacute Sequelae of COVID-19 Critical Illness. Schwab K; Schwitzer E; Qadir N Crit Care Clin; 2022 Jul; 38(3):455-472. PubMed ID: 35667737 [TBL] [Abstract][Full Text] [Related]
36. Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status. Xie Y; Bowe B; Al-Aly Z Nat Commun; 2021 Nov; 12(1):6571. PubMed ID: 34772922 [TBL] [Abstract][Full Text] [Related]
37. Plasma Biomarkers of Neuropathogenesis in Hospitalized Patients With COVID-19 and Those With Postacute Sequelae of SARS-CoV-2 Infection. Hanson BA; Visvabharathy L; Ali ST; Kang AK; Patel TR; Clark JR; Lim PH; Orban ZS; Hwang SS; Mattoon D; Batra A; Liotta EM; Koralnik IJ Neurol Neuroimmunol Neuroinflamm; 2022 May; 9(3):. PubMed ID: 35256481 [TBL] [Abstract][Full Text] [Related]
38. A Scoping Review of Pharmacological Management of Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 2021. Carson E; Hemenway AN Am J Ther; 2022 May-Jun 01; 29(3):e305-e321. PubMed ID: 35383586 [TBL] [Abstract][Full Text] [Related]